multi-locus genetic risk score study based combination loci including ABO gene identified individuals increased risk incident recurrent coronary artery disease events well enhanced clinical benefit statin therapy|multi-locus genetic risk score study based combination loci including ABO gene identified individuals increased risk incident recurrent coronacry artery disease events well enhanced clinical benefit statin therapy
multi-locus genetic risk score study based combination loci including ABO gene identified individuals increased risk incident recurrent coronary artery disease events well enhanced clinical benefit statin therapy|multi-locus genetic risk score study based combination loci inclding ABO gene identified individuals increased risk incident recurrent coronary artery disease events well enhanced clinical benefit statin therapy
multi-locus genetic risk score study based combination loci including ABO gene identified individuals increased risk incident recurrent coronary artery disease events well enhanced clinical benefit statin therapy|ulti-locus genetic risk score study based combination loci including ABO gene identified individuals increased risk incident recurrent coronary artery disease events well enhanced clinical benefit statin therapy
multi-locus genetic risk score study based combination loci including ABO gene identified individuals increased risk incident recurrent coronary artery disease events well enhanced clinical benefit statin therapy|multi-locus genetic risk score study based combination loci including ABO gene idenjtified individuals increased risk incident recurrent coronary artery disease events well enhanced clinical benefit statin therapy
multi-locus genetic risk score study based combination loci including ABO gene identified individuals increased risk incident recurrent coronary artery disease events well enhanced clinical benefit statin therapy|multi-locus gnetic risk score study based combination loci including ABO gne identified individuals increased risk incident recurrent coronary artery disease events well enhanced clinical benefit statin therapy
multi-locus genetic risk score study based combination loci including ABO gene identified individuals increased risk incident recurrent coronary artery disease events well enhanced clinical benefit statin therapy|multi-locus genetic risk score study based combination loci including ABO gene identified individuals increased risk incident recurrent coronary atery disease events well enhanced clinical benefit statin therapy
multi-locus genetic risk score study based combination loci including ABO gene identified individuals increased risk incident recurrent coronary artery disease events well enhanced clinical benefit statin therapy|multi-locus genetic risk score study based combination loci including ABO gene identified individuals increased risk incident recurrent coronary artery disease events well enhanced nlicical benefit statin therapy
multi-locus genetic risk score study based combination loci including ABO gene identified individuals increased risk incident recurrent coronary artery disease events well enhanced clinical benefit statin therapy|multi-locus genetic risk score study based combination loci including ABO gene identified individuals increased risk incident recurrent coronary artery disease events well enhanced clinical benefit stain therapy
multi-locus genetic risk score study based combination loci including ABO gene identified individuals increased risk incident recurrent coronary artery disease events well enhanced clinical benefit statin therapy|multi-locus genetic risk score study based combination loci including ABO gene identified individuals increased risk incident recurrent coronary artery disease events well enhanced clinical benefit statin thernapy
multi-locus genetic risk score study based combination loci including ABO gene identified individuals increased risk incident recurrent coronary artery disease events well enhanced clinical benefit statin therapy|multi-locus genetic risk score study based combination loci including ABO gene identified idividuals increased risk incident recurrent coronary artery disease events well enhanced clinical benefit statin therapy
